Paper Review Records
All Paper Review Records
4 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
49
days
Ocrelizumab Discontinuation vs. Continuation After Safety Events: Comparative Insights from MSBase
Authors
Aurora Zanghì; Tim Spelman; Marzena Fabis-Pedrini; William M. Carroll; Helmut Butzkueven; Allan G. Kermode; Jeannette Lechner-Scott; Anneke van der Walt; Emanuele D’Amico; the MSBase Study GroupShow moreShow less
Affiliations
1. Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy;; 2. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden;; 3. Perron Institute for Neurological and Translational Science, University of Western Australia, Nedlands, Australia;; 4. Personalised Medicine Centre, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia;; 5. Perron Institute for Neurological and Translational Science, Sir Charles Gairdner Hospital, QEIIMC, The University of Western Australia, Perth, Australia;; 6. Department of Neurology, The Alfred Hospital, Melbourne, Australia;; 7. Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia;; 8. Hunter Medical Research Institute, University Newcastle, Newcastle, Australia;; 9. Hunter New England Health, John Hunter Hospital, NSW, AustraliaShow moreShow less
98
days
Repetitive Transcranial Magnetic Stimulation Alters Brain Communication Networks to Improve the Cognitive Function in Patients with Amnestic Mild Cognitive Impairment - A Clinical Trial
Authors
Zhiyuan Yang; Moran Tangli; Yi Tan; Haojie Chen; Ni Shu; Zhihong Ke; Zheqi Hu; Qing Ye; Hailan Meng; Haifeng Chen; Yun XuShow moreShow less
Affiliations
1. Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China;; 2. State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China;; 3. Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China;; 4. Nanjing Neurology Clinical Medical Center, Nanjing, China;; 5. State Key Laboratory of Cognitive Neuroscience and Learning & IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China; 6. Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China;; 7. Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China;Show moreShow less
54
days
Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety
Authors
Chi Ma; Jingyi Shen; Ying Zhu; Benqiao Wang; Ruixia ZhuShow moreShow less
Affiliations
1. Department of Neurology, The First Affiliated Hospital of China Medical University, Key Laboratory of Neurological Disease Big Data of Liaoning Province, Shenyang Clinical Medical Research Center for Difficult and Serious Diseases of the Nervous System, Shenyang, ChinaShow moreShow less
107
days
Sleep Disorders in Moyamoya Disease: Prevalence, Risk Factors, and Impact on Functional Outcomes
Authors
Qingbao Guo; Manli Xie; Dan Yu; Cong Han; Yuqing Gao; Qian-Nan Wang; Xiangyang Bao; Lian DuanShow moreShow less
Affiliations
1. Department of Neurosurgery, Xi'an No.9 Hospital, 151 East Section of South Second Ring Road, Xi'an, Shaanxi, 710054, China;; 2. Department of Occupational Diseases, Xi'an Central Hospital, 161 West Fifth Road, Xi'an, Shaanxi, 710003, China;; 3. Department of Neurosurgery, the Fifth Medical Centre, Chinese PLA General Hospital, 8 Dongdajie, Beijing, 100071, China;; 4. Department of Neurosurgery, the Eighth Medical Centre, Chinese PLA General Hospital, No. A17, Heishanhu Road, Beijing, 100089, China;; 5. Department of Neurosurgery, the First Medical Centre, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100039, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days